142 related articles for article (PubMed ID: 28283542)
1. Sex difference in mouse metabolic response to erythropoietin.
Zhang Y; Rogers HM; Zhang X; Noguchi CT
FASEB J; 2017 Jun; 31(6):2661-2673. PubMed ID: 28283542
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin reduces fat mass in female mice lacking estrogen receptor alpha.
Lee J; Walter MF; Korach KS; Noguchi CT
Mol Metab; 2021 Mar; 45():101142. PubMed ID: 33309599
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific brain erythropoietin regulation of mouse metabolism and hypothalamic inflammation.
Dey S; Cui Z; Gavrilova O; Zhang X; Gassmann M; Noguchi CT
JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32078583
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin regulates metabolic response in mice via receptor expression in adipose tissue, brain, and bone.
Noguchi CT
Exp Hematol; 2020 Dec; 92():32-42. PubMed ID: 32950599
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin Non-hematopoietic Tissue Response and Regulation of Metabolism During Diet Induced Obesity.
Dey S; Lee J; Noguchi CT
Front Pharmacol; 2021; 12():725734. PubMed ID: 34603036
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin negatively regulates pituitary ACTH secretion.
Dey S; Scullen T; Noguchi CT
Brain Res; 2015 May; 1608():14-20. PubMed ID: 25765155
[TBL] [Abstract][Full Text] [Related]
7. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production.
Teng R; Gavrilova O; Suzuki N; Chanturiya T; Schimel D; Hugendubler L; Mammen S; Yver DR; Cushman SW; Mueller E; Yamamoto M; Hsu LL; Noguchi CT
Nat Commun; 2011 Nov; 2():520. PubMed ID: 22044999
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin signaling: a novel regulator of white adipose tissue inflammation during diet-induced obesity.
Alnaeeli M; Raaka BM; Gavrilova O; Teng R; Chanturiya T; Noguchi CT
Diabetes; 2014 Jul; 63(7):2415-31. PubMed ID: 24647735
[TBL] [Abstract][Full Text] [Related]
9. In vivo knockdown of adipocyte erythropoietin receptor does not alter glucose or energy homeostasis.
Luk CT; Shi SY; Choi D; Cai EP; Schroer SA; Woo M
Endocrinology; 2013 Oct; 154(10):3652-9. PubMed ID: 23885016
[TBL] [Abstract][Full Text] [Related]
10. The Many Facets of Erythropoietin Physiologic and Metabolic Response.
Suresh S; Rajvanshi PK; Noguchi CT
Front Physiol; 2019; 10():1534. PubMed ID: 32038269
[TBL] [Abstract][Full Text] [Related]
11. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
[TBL] [Abstract][Full Text] [Related]
13. The effects of erythropoietin dose titration during high-fat diet-induced obesity.
Foskett A; Alnaeeli M; Wang L; Teng R; Noguchi CT
J Biomed Biotechnol; 2011; 2011():373781. PubMed ID: 21541227
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin directly stimulates osteoclast precursors and induces bone loss.
Hiram-Bab S; Liron T; Deshet-Unger N; Mittelman M; Gassmann M; Rauner M; Franke K; Wielockx B; Neumann D; Gabet Y
FASEB J; 2015 May; 29(5):1890-900. PubMed ID: 25630969
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation.
Ge Z; Zhang P; Hong T; Tang S; Meng R; Bi Y; Zhu D
Sci Rep; 2015 Dec; 5():17878. PubMed ID: 26643367
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin receptor in B cells plays a role in bone remodeling in mice.
Deshet-Unger N; Kolomansky A; Ben-Califa N; Hiram-Bab S; Gilboa D; Liron T; Ibrahim M; Awida Z; Gorodov A; Oster HS; Mittelman M; Rauner M; Wielockx B; Gabet Y; Neumann D
Theranostics; 2020; 10(19):8744-8756. PubMed ID: 32754275
[TBL] [Abstract][Full Text] [Related]
17. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo.
Christensen B; Nellemann B; Jørgensen JO; Pedersen SB; Jessen N
Lipids Health Dis; 2016 Sep; 15(1):160. PubMed ID: 27640183
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles.
Hojman P; Brolin C; Gissel H; Brandt C; Zerahn B; Pedersen BK; Gehl J
PLoS One; 2009 Jun; 4(6):e5894. PubMed ID: 19521513
[TBL] [Abstract][Full Text] [Related]
20. Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats.
Caillaud C; Mechta M; Ainge H; Madsen AN; Ruell P; Mas E; Bisbal C; Mercier J; Twigg S; Mori TA; Simar D; Barrès R
J Endocrinol; 2015 May; 225(2):77-88. PubMed ID: 25767056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
